Journals / Türkiye Diyabet ve Obezite Dergisi / 2022 / Cilt: 6 - Sayı: 2

The Effects of 1,1-Dimethylbiguanide Hydrochloride (Metformin) on Detrusor Muscle Contractile Response in Ovariectomized Female Rats

Ovarektomize Dişi Sıçanlarda 1,1-Dimetilbiguanit Hidroklorid (Metformin)'in Detrüsör Kas Kontraktil Yanıtı Üzerine Etkileri

Pages
97–103
Publication Date
2022-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed for the therapeutic potential of MET in detrusor dysfunction induced by menopause.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Menopause is defined as the depletion of the ovarian follicular reserve followed by the cessation of menstrual cycles.
📊
Key Findings & Data:Changes in urine pattern including overactive bladder, stress incontinence and recurrent urinary tract infections occur as a result of menopause. 1,1-dimethylbiguanide hydrochloride, metformin, (MET) is an oral anti-diabetic drug used to reduce hepatic glucose production and peripheral insulin resistance.
💡
Conclusion & Impact:Further studies are needed for the therapeutic potential of MET in detrusor dysfunction induced by menopause.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ovarektomi · Detrusör kontraktilitesi · Menopoz

Abstract

Aim: Menopause is defined as the depletion of the ovarian follicular reserve followed by the cessation of menstrual cycles. It has been reported that gonadal steroid hormones play an important role in bladder function in women. Changes in urine pattern including overactive bladder, stress incontinence and recurrent urinary tract infections occur as a result of menopause. 1,1-dimethylbiguanide hydrochloride, metformin, (MET) is an oral anti-diabetic drug used to reduce hepatic glucose production and peripheral insulin resistance. Recent studies have revealed that MET has a protective effects in diabetes induced bladder dysfunction. The aim of this study was to test the therapeutic potential of MET in detrusor contractile function of ovariectomized (OVX) female rats. Material and Methods: Bilateral ovariectomy was performed to eliminate endogenous gonadal steroids secretion. Four groups are designed with 8 animals in each group: Control, MET-administered control, OVX, and MET-administered OVX groups. MET (25 mg/ kg) was administered daily by oral gavage for 14 days. Contractile activity of isolated bladder muscle strips were evaluated in vitro organ bath. The contractile responses of detrusor strips were determined using different doses of carbachol (10-8-10-2M) and purinergic agonist ATP. The relaxation response of strips were determined by isoproterenol Results: The contractile responses of detrusor muscle strips to carbachol at doses 10-5-10-2 M were decreased in the OVX group compared to control and MET treated control groups. MET treatment partially reversed the reduction in OVX-induced contractile responses at 10-2 and 10 -3 M carbachol doses. There were no statistically significant difference in relaxation response between the experimental groups. Conclusion: Our findings suggest that treatment with MET could be the new potential therapeutic agent against bladder dyfunction in postmenopausal women. Further studies are needed for the therapeutic potential of MET in detrusor dysfunction induced by menopause.

Özet

Amaç: Menopoz, yumurtalık foliküler rezervinin tükenmesi ve ardından adet döngüsünün durması olarak tanımlanır. Kadınlarda gonadal steroid hormonlarının mesane fonksiyonunda önemli rol oynadığı bildirilmiştir. Menopozun bir sonucu olarak idrar düzeninde değişiklikler meydana gelir. 1,1-dimetilbiguanid hidroklorür, metformin (MET), hepatik glukoz üretimini ve periferik insülin direncini azaltmak için kullanılan oral bir anti-diyabetik ilaçtır. Son zamanlarda yapılan çalışmalar, MET'in diyabetin neden olduğu mesane disfonksiyonunda koruyucu etkileri olduğunu ortaya koymuştur. Bu çalışmanın amacı, yumurtalıkları alınmış (OVX) dişi sıçanların detrusor kasılma fonksiyonunda MET'nin terapötik potansiyelini değerlendirmektir. Gereç ve Yöntemler: Endojen gonadal steroid sekresyonunu ortadan kaldırmak için bilateral ovariektomi yapıldı. Her grupta 8 hayvan olacak şekilde dört grup tasarlanmıştır: Kontrol, MET uygulanan kontrol, OVX ve MET uygulanan OVX grupları. MET (25 mg/kg) 14 gün boyunca oral gavaj yoluyla günlük olarak uygulandı. İzole mesane kas şeritlerinin kontraktil aktivitesi in vitro organ banyosunda değerlendirildi. Detrusor şeritlerinin kasılma yanıtları, farklı dozlarda karbakol (10-8-10-2M) ve purinerjik agonist ATP kullanılarak belirlendi. Striplerin gevşeme yanıtı izoproterenol ile değerlendirildi. Bulgular: Detrusor kas şeritlerinin 10-5-10-2 M dozlarda karbakole olan kontraktil yanıtları, OVX grubunda, kontrol ve MET ile tedavi edilen kontrol gruplarına kıyasla azaldı. MET tedavisi, 10-2 ve 10-3 M karbakol dozlarında OVX'in neden olduğu kasılma cevaplarındaki azalmayı kısmen tersine çevirdi. Deney grupları arasında gevşeme yanıtında istatistiksel olarak anlamlı bir fark yoktu. Sonuç: Bulgularımız, MET ile tedavinin postmenopozal kadınlarda mesane fonksiyon bozukluğuna karşı yeni potansiyel terapötik ajan olabileceğini düşündürmektedir. Menopozun neden olduğu detrusor disfonksiyonunda MET'nin terapötik potansiyeli için daha ileri çalışmalara ihtiyaç vardır.

🔖

Cite This Article

TURAN, İ., ERDEM, S., ERGENÇ, M., ÖZAÇMAK, H. S. (2022). The Effects of 1,1-Dimethylbiguanide Hydrochloride (Metformin) on Detrusor Muscle Contractile Response in Ovariectomized Female Rats. Türkiye Diyabet ve Obezite Dergisi, Cilt: 6 - Sayı: 2, 97–103. https://ajindex.com/articles/707712

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol. 2009; 23:25–32. 2. Ramos-Filho AC, Faria J, Calmasini FB, Teixeira SA, Mónica FZ, Muscará MN, Gontijo JA, Anhê GF, Zanesco A, Antunes E. The renin-angiotensin system plays a major role in voiding dysfunction of ovariectomized rats. Life Sci. 2013;93(22):820-9. 3. Breyer BN, Wang G, Lin G, Shindel AW, Yang R, Lin CS, Lue TF. The effect of long-term hormonal treatment on voiding patterns during filling cystometry and on urethral histology in a postpartum, ovariectomized female rat. BJU Int. 2010;106(11):1775-81. 4. Chen Y, Yu W, Yang Y, Duan J, Xiao Y, Zhang X, Wu S, Bai W. Association between overactive bladder and peri-menopause syndrome: a cross-sectional study of female physicians in China. Int Urol Nephrol. 2015;47(5):743-9. 5. Medina-Aguiñaga D, Munoz A, Luna M, Martinez-Moreno CG, Quintanar-Stephano A, Quintanar JL. Administration of leuprolide acetate, a GnRH agonist, improves urodynamic parameters in ovariectomized rats. Neurourol Urodyn. 2018;37(5):1574-1582. 6. Liang W, Afshar K, Stothers L, Laher I. The influence of ovariectomy and estrogen replacement on voiding patterns and detrusor muscarinic receptor affinity in the rat. Life Sci. 2002;71(3):351-62. 7. Bonilla-Becerra SM, de Oliveira MG, Calmasini FB, Rojas-Moscoso JA, Zanesco A, Antunes E. Micturition dysfunction in four-month old ovariectomized rats: Effects of testosterone replacement. Life Sci. 2017;179:120-129. 8. Chuang SM, Long CY, Lin RJ, Liu KM, Levin RM, Chang CY, Ho YW, Wu WJ, Chang WC, Juan YS. Protective effects of estrogen on ischemia/reperfusion-induced bladder dysfunction in female rabbits. Menopause. 2013;20(2):209-17. 9. Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril. 2006;85(1):155-60. 10. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008;148(6):459-73. 11. Yang S, Chen X, Xu Y, Hao Y, Meng X. Effects of metformin on lipopolysaccharide-induced depressive-like behavior in mice and its mechanisms. Neuroreport. 2020;31(4):305-310. 12. Shivavedi N, Kumar M, Tej GNVC, Nayak PK. Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats. Brain Res. 2017;16